BioCentury
ARTICLE | Clinical News

Merrimack preclinical data

December 17, 2012 8:00 AM UTC

In mouse models of breast cancer, tumor deposition of MM-DX-929 was significantly correlated with treatment response to MM-302 as measured by tumor volume changes on MRI over a 2-month period (p=0.0004). Additionally, MM-DX-929 accumulation in tumors prior to MM-302 treatment successfully predicted improved tumor growth inhibition following treatment with MM-302. Data were presented at the San Antonio Breast Cancer Symposium. ...